as on November 15, 2025 at 2:29 am IST
Day's Low
Day's High
0.81%
Downside
1.49%
Upside
52 Week's Low
52 Week's High
21.65%
Downside
37.21%
Upside
Check Mimedx Group, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.1B
EPS (TTM)
0.425
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
1.14%
PE Ratio (TTM)
27.33
Industry PE ratio
-0.8126129032258065
PEG Ratio
2.97
EBITDA
68.6M
Revenue (TTM)
393.4M
Profit Margin
10.38%
Return On Equity TTM
19.44%
Track how Mimedx Group, Inc. P/E has moved over time to understand its valuation trends.
Mimedx Group, Inc. in the last 5 years
Lowest (-161.05x)
March 31, 2021
Industry (-0.81x)
November 17, 2025
Today (27.33x)
November 17, 2025
Highest (31.60x)
September 30, 2025
Today’s Price to Earnings Ratio: 27.33x
Compare market cap, revenue, PE, and other key metrics of Mimedx Group, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.1B | 10.81% | 27.33 | 10.38% | |
| BUY | $60.0B | 247.38% | 1448.9 | 1.36% | |
| NA | $43.9B | NA | 717.29 | 1.38% | |
| BUY | $110.9B | 96.07% | 30.76 | 31.35% | |
| BUY | $73.0B | 28.87% | 16.61 | 32.13% |
The Mimedx Group, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Mimedx Group, Inc. investment value today
Current value as on today
₹84,876
Returns
Returns from Mimedx Group, Inc. Stock
Dollar Returns*
₹5,242 (+5.24%)
Based on 11 analysts
90.91%
Buy
9.09%
Hold
0.00%
Sell
Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Mimedx Group, Inc.. Average target price of $12.2
Get share price movements and forecasts by analysts on Mimedx Group, Inc..
What analysts predicted
39.43%UPSIDE
Target Price
$12.2
Current Price
$7.39
Analyzed by
11 Analysts
Target
$12.20
Mimedx Group, Inc. target price $12.2, a slight upside of 39.43% compared to current price of $7.39. According to 11 analysts rating.
Search interest for Mimedx Group, Inc. Stock has increased by 167% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:167% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
![]()
In the last 3 years, MDXG has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
![]()
In the last 1 month, MDXG stock has moved up by 10.3%
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 88.20M → 113.72M (in $), with an average increase of 11.9% per quarter
Profit Spike
![]()
Netprofit is up for the last 3 quarters, 7.02M → 16.74M (in $), with an average increase of 34.8% per quarter
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 93.3% return, outperforming this stock by 113.8%
| Organisation | Mimedx Group, Inc. |
| Headquarters | 1775 West Oak Commons Court, NE, Marietta, GA, United States, 30062 |
| Industry | Biotechnology |
| CEO | Mr. Joseph H. Capper |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Ricci S. Whitlow | Executive VP & COO |
Ms. Kimberly Maersk-Moller | Chief Commercial Officer |
Ms. Hilary Dixon | Vice President of Investor Relations & Corporate Strategic Communications |
Ms. Kate Surdez | Chief Human Resources Officer |
Mr. Joseph H. Capper | CEO & Director |
Mr. Douglas C. Rice CPA | Chief Financial Officer |
Mr. William F. Hulse IV | General Counsel & Chief Administrative Officer |
Mr. Matthew M. Notarianni | Head of Investor Relations |
Mr. Mark P. Graves | Senior VP & Chief Compliance Officer |
Dr. David H. Mason Jr., M.D. | Chief Medical Officer |
Mimedx Group, Inc. share price today is $7.39 as on at the close of the market. Mimedx Group, Inc. share today touched a day high of $7.5 and a low of $7.33.
Mimedx Group, Inc. share touched a 52 week high of $10.14 on and a 52 week low of $5.79 on . Mimedx Group, Inc. stock price today i.e. is closed at $7.39,which is 27.12% down from its 52 week high and 27.63% up from its 52 week low.
Mimedx Group, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Mimedx Group, Inc. (MDXG) shares with as little as ₹88.74 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹887.40 in Mimedx Group, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Mimedx Group, Inc. share’s latest price of $7.39 as on November 15, 2025 at 2:29 am IST, you will get 1.3532 shares of Mimedx Group, Inc.. Learn more about
fractional shares .
Mimedx Group, Inc. stock has given 10.81% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?